期刊文献+

失重环境药物代谢动力学研究 被引量:4

Research on pharmacokinetics in weightless environment
暂未订购
导出
摘要 航天药代动力学是航天医学的重要组成部分。航天失重引起的机体生理、生化功能变化进而导致药物的代谢动力学特征发生改变,是影响航天用药的关键因素之一。本文从失重的实验模型,失重对药物吸收、分布、代谢和排泄各环节的影响以及失重条件下药动学研究的影响因素进行综述,为航天药代动力学研究提供一定参考。 Space pharmacokinetics is an important part of aerospace medicine. The change of pharmacokinetics caused by the change of physiological and biochemical function of weightlessness in space,is one of the key factors influencing the use of medicine. This article reviewed the research progress including experimental models,the effects on the ab-sorption,distribution,metabolism and excretion of drugs,and the influencing factors of pharmacokinetics of weightlessness,which may provide some reference for space pharmacokinetics.
作者 王小青 周杰兆 程泽能 姜德建 WANG Xiaoqing ZHOU Jiezhao CHENG Zeneng JIANG Dejian(pharmacy Department of Central South University School of Medicine, Engineering Technology Research Center for Optimization and Early Clinical Evaluation of Pharmaceutical Preparation in Hunan Province, Changsha 410013, Hunan, China Hunan Center for Safety Evaluation and Research of Drugs, Hunan Key Ixtboratory for Pharmacodynamics and Safety Evaluation of new drugs, Changsha 410013, Hunan, China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2017年第6期709-712,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 湖南省科技计划(2015DK3010) 湖湘青年创新人才基金(2014) 人因工程国家重点实验室开放课题(SYFD150051808K)
关键词 失重 药物代谢动力学 weightless pharmacokinetics
  • 相关文献

参考文献6

二级参考文献86

  • 1沈羡云,孟京瑞,王玉清,向求鲁,杨光华,史之祯,刘成林.头低位-20°限制活动期间兔生理指标的变化[J].航天医学与医学工程,1994,7(3):186-191. 被引量:31
  • 2丁龙其,张荣珍.微生物法测定家兔中庆大霉素药代动力学的实验[J].现代应用药学,1994,11(2):24-25. 被引量:2
  • 3美国雅培公司.TDx操作手册[M].,..
  • 4SCHROEDER W ,Ghobrial L ,Gandhi P. Possible mechanisms of drug-induced aspirin and clopidogrel resistance [J].Journal of Thrombosis and Thrombolysis, 2006,22 ( 2 ) : 139- 150.
  • 5COZZA K L, ARMSTRONG S C, OESTER HELD J R. Drug interactions by medical specialty. In:Concise Guide to Drug Interaction Principles for Medical Practice: Cytochrome P450s, UGTs, P-Glycoproteins [M]. 2nd ed. Washington D C: American Psychiatric Pub, 2003,167-396.
  • 6ZEVIN S, BENOWITZ N L. Drug Interactions with Tobacco Smoking : An Update[J]. Clinical Pharmacokinetics, 1999,36 : 425-438.
  • 7DE LEON J, DIAZ F J, ROGERS T, et al. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers [J]. Prog Neuropsychopharmaeol Biol Psychiatry, 2003,27 (1) : 165-171.
  • 8NGUYEN M ,CHUNG E P. Telithromycin :The first ketolide antimicrobial [J]. Clinical Therapeutics, 2005,27 (8) : 1144-1163.
  • 9SLAUGHTER R L, EDWARDS D J. Recent advances: the cytochrome P450 enzymes [J].Ann Pharmacother, 1995,29 : 619-624.
  • 10WEINSHILBOUM R. Inheritance and Drug Response [J]. N Engl J Med,2003,348(6): 529-537.

共引文献76

同被引文献32

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部